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WiskotteAldrich Syndrome protein (WASp) regulates the cytoskeleton in hematopoietic cells and mu-
tations in its gene cause the WiskotteAldrich Syndrome (WAS), a primary immunodeﬁciency with
microthrombocytopenia, eczema and a higher susceptibility to develop tumors. Autoimmune manifes-
tations, frequently observed in WAS patients, are associated with an increased risk of mortality and still
represent an unsolved aspect of the disease. B cells play a crucial role both in immune competence and
self-tolerance and defects in their development and function result in immunodeﬁciency and/or auto-
immunity. We performed a phenotypical and molecular analysis of central and peripheral B-cell com-
partments in WAS pediatric patients. We found a decreased proportion of immature B cells in the bone
marrow correlating with an increased presence of transitional B cells in the periphery. These results
could be explained by the defective migratory response of WAS B cells to SDF-1a, essential for the
retention of immature B cells in the BM. In the periphery, we observed an unusual expansion of CD21low
B-cell population and increased plasma BAFF levels that may contribute to the high susceptibility to
develop autoimmune manifestations in WAS patients. WAS memory B cells were characterized by a
reduced in vivo proliferation, decreased somatic hypermutation and preferential usage of IGHV4-34, an
immunoglobulin gene commonly found in autoreactive B cells.
In conclusion, our ﬁndings demonstrate that WASp-deﬁciency perturbs B-cell homeostasis thus
adding a new layer of immune dysregulation concurring to the increased susceptibility to develop
autoimmunity in WAS patients.
 2013 The Authors. Published by Elsevier Ltd.Open access under CC BY-NC-ND license. BY-NC-ND license (http://
itute for Gene Therapy (HSR-
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Ltd. Open access under CC BY-NC-ND1. Introduction
WiskotteAldrich Syndrome (WAS) is a monogenic X-linked
primary immunodeﬁciency characterized by the classic triad of
microthrombocytopenia, eczema and recurrent infections. Multiple
autoimmune manifestations and tumors are serious complications
and the life expectancy of WAS patients is severely reduced, unless
they are successfully cured by hematopoietic stem cell trans-
plantation [1]. license. 
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the expression and/or function of the WAS protein (WASp),
a hematopoietic-speciﬁc regulator of cytoskeletal reorganization
also involved in signal transduction of cells [4]. The absence or
reduction of WASp compromises multiple processes of different
immune cell types involved in innate and adaptive responses,
resulting in a variable and progressive immunodeﬁciency. Auto-
immune complications affect 22e72% of WAS patients and are
associated with poor prognosis [5,6]. Susceptibility of WAS patients
to develop autoimmune diseases has been mainly attributed to the
breakdown of self tolerance sustained by dysfunction of both nat-
ural T regulatory and effector T cells (reviewed in Ref. [7]). However,
B-cell intrinsic defects have been demonstrated to critically
contribute to WAS-associated autoimmunity in Was/ mouse
model [8,9]. In humans, the contribution of B-cell defects in the
pathogenesis of WAS has been partially investigated. B cells from
patients exhibit lower motility, migratory and adhesive capacities
[10], likely due to defective F-actin nucleation [11]. In contrast,
despite the role of WASp in B-cell receptor (BCR) signaling [7,12],
abnormalities in B-cell activation still remain controversial [13,14].
A skewed distribution of serum immunoglobulin (Ig) classes [5]
and the inability to mount a proper antibody response, particu-
larly to T-cell independent (TI) antigens [15], suggest defects in B-
cell effector function.
Previous ﬁndings in WAS patients [16,17] show phenotypical B-
cell perturbations in the periphery. In order to evaluate whether an
abnormal B-cell development might generate a B-cell repertoire
unable to unsure full protection against pathogens and tolerance
against self-antigens, we have further studied the B-cell compart-
ment in WAS patients. To this end, we have combined a detailed
phenotypical analysis of B-cell maturation stages, from the bone
marrow (BM) to the periphery, with a molecular study of Ig
repertoire and in vivo B-cell maturation processes in a large cohort
of WAS pediatric patients. Our data show that WASp-deﬁciency
affects critical stages of central and peripheral B-cell differentia-
tion contributing to abnormalities in humoral immunity and B-cell
tolerance in humans.
2. Material and methods
2.1. Patients
The diagnoses were clinically deﬁned and conﬁrmed by genetic
analysis. A description of all patients is reported in Supplementary
Table 1. Human samples were obtained according to The Code of
Ethics of the World Medical Association (Declaration of Helsinki)
with the approval of the local Medical Ethical Committees of the
ErasmusMC and the San Raffaele Scientiﬁc Institute Internal Review
Board (TIGET02). All legal representatives gave written informed
consent. All results obtained from samples of WAS patients were
compared to age and sex matched healthy donors (HDs).
2.2. Flow cytometry and puriﬁcation of B-cell subsets
The composition of the precursor B-cell compartment was
analyzed by ﬂow cytometric immunophenotyping as described in
the Supplementary Material. For the analysis of replication his-
tory and somatic hypermutation, four B-cell subsets were isolated
from thawed peripheral blood mononuclear cells (PBMCs) using
a FACS DiVa cell sorter (BD Biosciences) [18]. Gating on CD19þ
cells, transitional (CD27CD24highCD38high), mature naïve
(CD27IgDþCD24dimCD38dim), natural effector (CD27þIgDþ) and
memory (CD27þIgD) B-cell subsets were sorted with a purity of
>95% for all fractions. For intracytoplasmic detection of human
WASp, cells were ﬁxed and permeabilized using a Cytoﬁx/Cytoperm kit (BD Pharmingen, Oregon, USA). The anti-WASp
antibody 503 (a kind gift from Prof H. D. Ochs, Seattle, WA, and
L. D. Notarangelo, Boston, MA) was used, followed by detection
with Paciﬁc Blue-labeled anti-rabbit IgG secondary antibody
(Invitrogen, San Diego, USA). Samples were acquired on a FACS-
Canto cytometer.
2.3. Chemotaxis assay
CD20 positive cells were puriﬁed from PBMCs of pediatric
WAS patients and age-matched HDs by immunomagnetic beads
(Miltenyi Biotec, Germany) or FACS sorting. The purity of the
isolated cells were analyzed by FACS and ranged from 84% to
98%. After isolation, cells were left overnight at 37 C in culture
medium composed of RPMI-1640, 10% FBS, 2 mM glutamine,
100 IU/mL penicillin and 100 mg/mL streptomycin (Lonza, Basel,
Switzerland). In vitro chemotaxis assay was performed using 5 mM
pore-size Transwell inserts (Costar Corporation, Corning, NY, US)
in 24-well plates. Filters were prewet 30 min at 37 C in presence
of 600 mL of medium supplemented with 250 ng/mL of recom-
binant human stromal cell-derived factor (SDF)-1a (CXCL12;
Peprotech, Rocky Hill, US). Fifty thousand CD20 positive or
negative cells were resuspended in 100 mL of culture medium,
seeded in the upper chamber and incubated at 37 C for 3 h.
Transmigrated cells, collected in the lower chamber, were coun-
ted for viable cells and stained with anti-CD19, anti-CD24, anti-
CD38, anti-CD27 and anti-CD3 (BD Biosciences) for the pheno-
typical analysis by FACS. Migration frequency was estimated as
the [(cell n at the lower chamber/the initial B cell input in the
upper chamber)  100].
2.4. ELISA assay
Levels of B-cell activating factor (BAFF) were measured in
duplicate in plasma samples of WAS patients and HDs using a
Quantikine Human BAFF/BLyS/TNFSF13B Immunoassay kit (R&D
Systems, Minneapolis, USA). The assay was performed according to
manufacturer’s instructions and the OD was determined using a
microplate reader set to 450 nm.
2.5. Sequence analysis of Igk and IGH gene rearrangements
RNA was isolated from PBMCs and reverse-transcribed using
random hexamers. Igk and IGH gene rearrangements were ampli-
ﬁed and analyzed as described in the Supplementary Material.
2.6. Analysis of replication history by KREC assay
DNAwas extracted from sorted B-cell subsets with the GenElute
Mammalian Total DNA Miniprep kit (SigmaeAldrich) and used to
perform the Igk-deleting recombination excision circles (KREC)
assay [19]. The amounts of coding and signal joints of the Igk-de-
leting rearrangement were measured by real-time quantitative PCR
on an ABI Prism 7000 sequence detection system (Applied
Biosystems).
2.7. Analysis of somatic hypermutation by IgkREHMA
Igk restriction enzyme-based hot-spot mutation assay
(IgkREHMA) was performed on genomic DNA isolated from sorted
B-cell subsets [19]. Brieﬂy, Vk3-20-Jk rearrangements were PCR-
ampliﬁed and the PCR products (w500 bp) were ﬁrst digested
using the restriction enzyme Fnu4HI and then KpnI. The unmutated
gene products can be visualized as 244 or 247 bp HEX-coupled
fragments and the mutated as 262 bp HEX-coupled fragment.
M.C. Castiello et al. / Journal of Autoimmunity 50 (2014) 42e50442.8. Statistical analyses
All results are expressed as mean and SD if not stated otherwise.
Statistical signiﬁcance was assessed using a two-tailed Mann
Whitney test. Comparisons between proportions were calculated
by using the chi-square test (c2 test) (with continuity correction). P
values of less than 0.05 were considered signiﬁcant.
3. Results
3.1. Altered distribution of the precursor B-cell compartment in the
bone marrow of WAS patients
Until now, the composition of the B-cell compartment in the
BM of WAS patients has not been reported. To evaluate the effect
of WASp-deﬁciency on B-cell development in the BM, we char-
acterized ﬁve stages of B-cell differentiation [20] in three WAS
patients. We observed a decreased frequency of immature B
lymphocytes in WAS patients (Fig. 1A). This observation was
further assessed in four additional patients, focusing on late
stages of B-cell differentiation based on the expression of CD10
and CD20 [21] (gating strategy is shown in Suppl. Fig. 1). We
conﬁrmed a signiﬁcant decrease in the frequency of immature B
cells compared with age-matched HDs (Fig. 1B). In addition, at the
earliest differentiation stages, we observed a signiﬁcant increase
of small Pre-B-II cells in WAS patients; while no statistical dif-
ference was detected in large Pre-B-II cell frequency (Fig. 1C).
These ﬁndings might reﬂect a partial block in the BM B-cell dif-
ferentiation between the small Pre-B-II and immature B-cell
stages in WAS, or an early egress of immature B cells into the
periphery.
3.2. Perturbed peripheral B-cell maturation in WAS patients
Next we examined the distribution of B-cell subsets in the pe-
ripheral blood of WAS patients and age-matched HDs. When
available, we evaluated the absolute count of total B cells, which was
found signiﬁcantly reduced in patients less than three years old0% 20% 40% 6
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Fig. 1. Reduced frequency of immature B cells in WAS BM samples. A. The precursor B-cell
contamination) and compared with the average values of age-matched HDs (y ¼ years). BeC
Pre-B-II large (CD10intCD20int) cells (C) were determined on CD34CD19þ cells and calculat
The graphs show data points for all examined donors and patients. ***P < 0.0001; **P ¼ 0(<3y), while no differences were observed in the older WAS group
(Fig. 2A) conﬁrming previously published results [16]. Four B-cell
subsets were identiﬁed according to the expression of CD24, CD38,
IgD and CD27: transitional, mature naïve, memory and plasmablasts
(Fig. 2B). Transitional B cells (CD24hiCD38hi) are the most immature
peripheral B-cell population that were signiﬁcantly increased in
both WAS age groups as frequency (Fig. 2C) and absolute number
(Suppl. Fig. 2). The next maturation stage, represented by mature
naïve B cells (CD27IgDþCD24dimCD38dim), was signiﬁcantly
decreased only in WAS patients less than 3 years old both in fre-
quency (Fig. 2C) and absolute number (Suppl. Fig. 2). Finally, the
frequency of plasmablasts (CD24CD38hi) was signiﬁcantly
increased in the older group of patients (Fig. 2C), while the absolute
number of both memory B cells (CD27þIgDCD24dimCD38dim) and
plasmablasts were signiﬁcantly decreased in the younger group of
WAS patients (Suppl. Fig. 2).
Altogether, these ﬁndings demonstrate thatWAS patients have a
perturbed peripheral B-cell distribution.3.3. B lymphocytes from WAS patients display a reduced migratory
ability in response to SDF-1a
The overrepresentation of transitional B cells in the blood of
WAS patients led us to hypothesize that an early egress of
immature B cells from BM could occur. CXCR4, the chemokine
receptor for SDF-1a, has an important role in retaining B-cell
precursors within the BM in order to prevent premature migra-
tion to the periphery [22e24]. We tested the chemotactic
response to SDF-1a of B lymphocytes of WAS patients and HDs by
transwell migration assay. As shown in Fig. 3, both transitional
and mature peripheral B cells were less responsive to SDF-1a
in the absence of WASp (Fig. 3AeC). This defect was speciﬁc for
B lymphocytes since CD3 positive cells of WAS patients showed a
normal migratory capacity to SDF-1a (Suppl. Fig. 3). Thus, we
hypothesize that a diminished retention signal mediated by
CXCR4/SDF-1a could explain the premature egress of immature
B cells from the BM leading to an increase of transitional B cells in
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differentiation pattern in the BM was analyzed by ﬂow cytometry (corrected for blood
. Frequencies of Immature B cells (CD10intCD20þ) (B), Pre-B-II small (CD10intCD20) and
ed on total BM precursor B cells excluding recirculating mature B cells (CD10CD20þ).
.0029. (HD, n ¼ 27; WAS, n ¼ 7).
Fig. 2. Perturbed peripheral B-cell maturation in WAS patients. A. Absolute counts of CD19þ cells of WAS patients (black dots) and age-matched HDs (white dots) were analyzed
when available. B. Representative plots of ﬂow cytometric analysis of blood B-cell subsets of a HD and a WAS patient (age range: <3y) are shown. C. Graphs display frequencies of
the four main B-cell subsets in the blood of WAS patients and age-matched HDs. Individual data points are displayed with mean and SD. Groups are compared to controls and
signiﬁcant values are indicated: ***P  0.0005; **P < 0.005; *P < 0.05. (HD < 3y, n ¼ 29; HD 3e12y, n ¼ 27).
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B-cell subsets and elevated B-cell activating factor plasma levels
To further characterize the peripheral B-cell distribution, we
focused our analysis on B-cell subsets found expanded in autoim-
mune diseases and potentially autoreactive [25e28]. We found a
signiﬁcant increase of CD19þCD21CD35 subset in both WAS age
groups (Fig. 4A), conﬁrming data previously reported by Park
and colleagues [17]. We also analyzed the frequency of
CD19þCD21CD38 cells (referred to as CD21low) described to be
expanded in autoimmune diseases and immunodeﬁciencies [26,27]
[29]. Interestingly, we observed that the frequency of this unusual
population was markedly increased in WAS patients, both in the
younger and older groups (Fig. 4B). In addition, higher levels of
soluble BAFF were found in the plasma of WAS patients as
compared to pediatric HDs (Fig. 4C). This ﬁnding was also associ-
ated with a decreased expression of its receptor, BAFFR, in transi-
tional B cells of WAS patients (Fig. 4D). Because of the role of BAFF
in B-cell homeostasis and peripheral B-cell tolerance [30,31], high
BAFF levels may affect the stringency of peripheral B-cell selectionthus favoring the survival of B-cell subsets containing potentially
autoreactive clones.
3.5. WASp-deﬁciency affects antigen-dependent B-cell
differentiation and maturation
In order to evaluate the effect of WASp-deﬁciency in an antigen
dependent context, we analyzed in detail the memory B-cell
compartment of WAS patients. We identiﬁed six distinct memory
B-cell subsets [32] (gating strategy is shown in Suppl. Fig. 4):
CD27þIgMþIgD (also named “IgM-only”) and CD27IgGþ deriving
from primary germinal center (GC) responses; IgGþ CD27þ and
IgAþ CD27þ switched memory B cells originating from secondary
GC responses; CD27þIgDþ (named “natural effector”) and
CD27IgAþ generated in a TI manner in the gastrointestinal tract or
in the splenic marginal zone area, respectively [33]. We did not
observe differences in memory B-cell populations deriving from
both primary and secondary GC responses between WAS patients
and HDs (Fig. 5AeB). A marked reduction in natural effector B cells
was found in both age groups of WAS patients both as frequency
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Fig. 3. Reduced in vitro migration to SDF-1a of B cells from WAS patients. CD20 positive cells were isolated from PBMCs of WAS patients (black bars; n ¼ 4) and age matched HDs
(white bars; n ¼ 5) and subjected to the chemotaxis assay in the presence of 250 ng/mL of SDF-1a or medium alone. The percentage of migrated CD19þ cells (A),
CD19þCD24hiCD38hi transitional (B) and CD19þCD24dimCD38dim mature B cells (C) were determined by ﬂow cytometric analysis. The graphs summarize three independent ex-
periments and represented as bars with mean and SEM. WAS Groups are compared to HDs and statistically signiﬁcant values are indicated: **P < 0.005; *P < 0.05.
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CD27IgAþ B cells was decreased in 3e12 years old patients
compared with HDs (Fig. 5C). In conclusion, the absence of WASp
mainly affects TI responses of B cells, whereas only mildly impairs
the generation of early memory B cells in GC without inﬂuencing
the class-switched memory B-cell compartment.
We determined the in vivo B-cell proliferation history by KREC
assay and in parallel SHM by IgkREHMA in sorted transitional,
mature naïve, natural effector and memory B cells. As expected,
transitional B lymphocytes did not undergo cell divisions andFig. 4. Presence of B-cell populations potentially autoreactive with increased BAFF levels in
show the decreased expression of CD21 and CD35 (A) and the frequency of CD21low B cells
graphs. C. Bar graph, with mean and SD, shows BAFF levels in plasma of WAS patients and H
transitional B cells of representative WAS (Pt20, gray line) and HD (black line) subjects. Solid
(MFI) of BAFFR. Signiﬁcant values compared to normal controls are indicated: ***P  0.000mature naïve B cells had a limited number of cell divisions in HDs
(Fig. 6A). In HDs both B-cell subsets were characterized by the
absence of SHM (Fig. 6B) and we did not ﬁnd differences in tran-
sitional and mature naïve B cells of WAS subjects (Fig. 6AeB). In
contrast, the memory compartment showed less proliferation in
WAS memory B cells in association with a reduced SHM level
(Fig. 6AeB). Interestingly, the defect in maturation was even more
pronounced in natural effector WAS B lymphocytes. To study SHM
also in the Ig heavy chain (IGH), we analyzed the frequency of
mutated nucleotides in rearranged Variable region of IGH (IGHV)WAS patients. A-B. Representative plots (left panels) and relative graph (right panel)
(B) gated on CD19þ cells in WAS patients. Individual data points are displayed in the
Ds with an age range of 0e5 year old. D. Histogram shows the expression of BAFFR in
gray curve is the unstained control. Bar graph shows the mean ﬂuorescence intensity
5; **P < 0.005; *P < 0.05.
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groups, the IGHV3 and IGHV4 gene families [34], of both g- and a-
chain of Constant regions (Cg and Ca). The mutational frequency of
WAS B cells was signiﬁcantly lower for both Cg and Ca transcripts in
all domains of V region (Fig. 6C and Suppl. Fig. 6). Thus, the
decreased in vivo proliferation and SHM levels of WAS memory B
cells could be responsible of a lower protection against infections
and persistence of pathogens that ﬁnally lead to autoimmunity.
3.6. Altered selection of antibody repertoire in B cells from WAS
patients
Next we studied the IGHV gene repertoire within the IGHV3 and
IGHV4 subgroups. WAS B cells showed an increased frequency of
IGHV3-30 in both Ig classes (Fig. 7A and Suppl. Fig. 7A) and the
absence of IGHV3-48 genes in Ca sequences (Suppl. Fig. 7A). In
IGHV4 transcripts, we noticed a dominant usage of the IGHV4-34
genes in WAS Cg (Fig. 7B) and Ca transcripts (Suppl. Fig. 7B), also
characterized by lower mutation frequency (Fig. 7C) [35]. Moreover,
the antibody repertoire of WAS B cells was devoid of IGHV4-59, a
gene commonly used in B cells from HDs [36]. The distribution of D
families was only slightly altered inWAS patients (Suppl. Fig. 7CeD).Finally, we evaluated the CSR process in total B cells by analyzing
the frequency of Ig subclasses in sequenced IGH transcripts. A
preferential usage of g-chain C region 3 (Cg3) and Cg1, IGH-
proximal genes (the IGH locus is schematized in Fig. 7D), accom-
panied by a reduction in the expression of distal Cg2 and Cg4, were
detected in WAS patients (Fig. 7E). The analysis of IgA transcripts
showed no signiﬁcant difference in the subclass usage (Fig. 7E). In
conclusion WAS patients show a skewed Ig gene usage suggesting
an altered selection of the antibody repertoire during B-cell
development.
4. Discussion and conclusions
We reported herein that WASp-deﬁciency affects many aspects
of B-cell development, ﬁrst in the BM and then in the periphery.
Indeed, precursor B-cell as well as memory B-cell development and
selection appear affected by the absence of functional WASp.
In the BMwe have observed a decreased frequency of immature
B cells, while in the periphery an overrepresentation of transitional
B cells likely due to a reduced retention in the BM and/or a
decreased migration to peripheral lymphoid tissues. The interac-
tion of the chemokine receptor CXCR4 with its ligand SDF-1a is
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WASp is actively involved in CXCR4 signaling [37e39] and Was/
murine B cells show defective migratory response to SDF-1a [10].
Consistently, here we demonstrate in WAS patients that B cellsFig. 7. Skewed Ig gene usage of WAS B cells. A-B. Graphs show the frequency of IGHV3 (A) an
(panel AeB, n ¼ 12). Total number of analyzed sequences is reported in brackets. C. Graph i
sequences within the FR1 region. D. Schematic representation of the constant region of the h
used in IGH rearrangements of B cells are represented in the pie charts reﬂecting their order
of each pie. Differences were statistically analyzed by c2 test (*P < 0.05).migrate less to SDF-1a. Thus,WAS immature B cells could be unable
to properly sense retention signals derived from CXCR4 in the BM
leading to a premature release in the periphery. The increase of
transitional B cells could also reﬂect an altered migration to thed IGHV4 (B) genes used by IgG of HDs (panel A, n ¼ 7; panel B, n ¼ 5) and WAS patients
ndicates the percentage of mutated (W7, A23, Y25 positions) or not mutated IGHV4-34
uman IGH locus. EeF. Percentage distribution of IgG (E) and IgA (F) receptor subclasses
in the human IGH locus. Total number of analyzed sequences is indicated in the center
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the circulation. Consistently, our data allow us to exclude that the
expansion of transitional B cells is due to homeostatic proliferation
since we demonstrated the absence of replication history in this
subset.
Transitional B cells are found expanded in immunodeﬁcient
conditions [40] or autoimmune diseases [41] and represent a
reservoir of autoreactive B cells [42]. The cohort of patients
analyzed here did not show any overt sign of autoimmunity,
probably due to their young age. However, the analysis of serum
autoantibodies performed in four patients showed positivity for
anti-nuclear antibodies in three patients. One of them also showed
the presence of anti-platelet antibodies (data not shown). Impor-
tantly, an increased frequency of CD21low B cells was observed.
These cells are enriched in anergic autoreactive clones [26] and
expanded in systemic lupus erythematosus (SLE), rheumatoid
arthritis and in common variable immunodeﬁciency groupIa pa-
tients developing autoimmune syndromes [26,28]. BAFF levels and
signals through BAFFR coordinate the maintenance of the primary
B-cell pool and the fate of self-reactive B cells [30]. Herein, we
report for the ﬁrst time increased BAFF levels and decreased BAFFR
expression in WAS patients. Elevated BAFF serum levels are often
present in immunodeﬁciencies [43], autoimmune diseases [44,45]
and viral infections [46] and may lower the thresholds for the
survival of autoreactive B cell clones [30]. The enrichment of
CD21low B cells and the alterations in BAFF levels and expression of
its receptor suggest that the mechanisms of B-cell selection could
be altered in WAS patients. Our data also suggest the presence of a
defective selection of WAS B cells producing high-afﬁnity anti-
bodies. Indeed, we noticed a restricted or null presence of IGHV3-
48 and IGHV4-59 gene families and a preferential usage of
IGHV3-30 and IGHV4-34. In particular, IGHV3-48 gene is selectively
used against polysaccharide antigens [47] and its decrease in WAS
could account for an inefﬁcient antibody response. In contrast,
IGHV3-30 is highly represented among anti-platelet autoantibodies
from patients with idiopathic thrombocytopenic purpura [48] and
in SLE patients [49]. Additionally, IGHV4-34 e encoded antibodies
are intrinsically autoreactive when unmutated [35,50], as observed
in our patients. This peculiar antibody repertoire reﬂects an altered
selection of both protective and autoreactive Ig gene families. The
perturbation of B-cell homeostasis present in WAS patients sup-
ports the administration of anti-CD20 mAb in the conditioning
regimen of gene therapy to deplete B cells [51].
In the memory B-cell compartment, the frequency of isotype-
switched IgGþ B cells was found normal in WAS patients, despite
a deﬁcit of CD27þ B cells [17]. We observed a normal frequency of
memory B cells and of switched CD27þIgGþ and CD27þIgAþ B cells
in our cohort of WAS patients. This suggests that T-cell dependent
antigen response is induced normally in WAS patients. In contrast,
the frequency and the SHM level of TI memory B-cell subsets were
reduced, likely due to their reduced in vivo proliferation. The
marked reduction in the natural effector B-cell subset, resembling
marginal zone B cells in the spleen, mirrors the decreased number
of splenic marginal zone B cells and the histological defects in the
marginal zone area of the spleen already described in Was/mice
[9,52,53] and patients [54]. In addition, both the reduction in nat-
ural effector and IgAþCD27 B cells, which are generated during TI
responses, provide evidence of a defect in B-cell function inde-
pendent from the cross-talk with T lymphocytes.
The mutational status of both heavy and light Ig chains is
reduced in WAS in presence of a diminished rate of proliferation in
the total memory B-cell pool. In addition, the analysis of Ig gene
selection showed a preferential use of IGH-proximal genes (IGHG1
and IGHG3) accompanied by reduced SHM suggesting that WAS B
cells have undergone less GC reactions [33]. Reduced IgG2switching inWAS patients could account for the poor response toTI
antigens which is typical of the syndrome [15]. The cytokine proﬁle
of WAS patients shows an impairment in the production of Th1
cytokines [7] that could explain their reduced switching to IgG2
subclass. Moreover, the isotype-switching outcome is also inﬂu-
enced by two additional factors: cell division [55] and antibody
afﬁnity to antigens [56]. The defective proliferation of memory and
natural effector B cells and the reduced afﬁnity maturation found in
WAS might contribute to these alterations in class switching.
Our results in WAS patients show an early egress of immature B
cells from BM leading to an overrepresentation of transitional B
cells in the periphery. The memory compartment is characterized
by a reduced maturation status that could affect the B-cell effector
functions contributing to a lower clearance of pathogens and
leading to chronic inﬂammation that can break tolerance.
In conclusion, our results add novel immunological features of
WAS B-cell phenotype that can complement the evaluation of the
efﬁcacy of various treatment approaches.
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